查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1424096

雙胍市場、份額、規模、趨勢、行業分析報告：按類型、分銷管道、地區、細分市場預測，2024-2032

Biguanides Market Share, Size, Trends, Industry Analysis Report, By Type (Metformin, Phenformin, Others); By Distribution Channel; By Region; Segment Forecast, 2024- 2032
出版日期: | 出版商: Polaris Market Research | 英文 116 Pages | 商品交期: 最快1-2個工作天內

價格

根據Polaris Market Research的最新研究，到2032年，全球雙胍類藥物市場規模預計將達到61.9億美元。 該研究報告提供了對當前市場動態的詳細洞察，並對未來市場成長進行了分析。

持續努力的重點是配方創新、探索聯合療法以及擴大雙胍類藥物在糖尿病治療中的使用。 提高臨床療效、安全性和病患治療效果的努力體現在對新型藥物傳遞系統和製劑的探索中。 此外，為了擴大雙胍類藥物的治療範圍，我們也正在研究其在血糖控制以外的心臟代謝系統中的潛在用途。 製藥公司和學術機構之間的合作研究正在推動創新，並確保持續的研究有助於雙胍類藥物在動態的抗糖尿病治療領域中的持續相關性。

遠距醫療整合是雙胍類市場成長的驅動力。 隨著糖尿病管理向個人化護理發展，遠距醫療平台簡化了遠距患者監測，以獲得更好的結果。 即時追蹤血糖水平和藥物依從性可以提高雙胍藥物的有效性，尤其是在糖尿病的治療中。 虛擬就診可以快速調整藥物治療方案並鼓勵患者參與。 這種整合不僅改善了患者護理，還為正在進行的糖尿病管理研究提供了寶貴的數據。 遠距醫療提供的便利性將提高患者的依從性，刺激對雙胍藥物的需求，並推動市場擴張。

以患者為中心的配方正在推動雙胍市場的擴張。 與個人化醫療保健的趨勢一致，這些量身定制的配方，包括緩釋選項，正在增加雙胍類藥物的吸引力和功效。 最大限度地減少副作用並簡化給藥方案，以提高用藥依從性並優先考慮患者的舒適度和依從性。 提高滿意度和藥物依從性不僅可以優化治療結果，還可以增加雙胍類藥物的市場需求。

聯合療法透過探索雙胍藥物與其他治療類別之間的協同作用，正在推動雙胍市場的成長。 這項研究和開發為提高治療效果提供了新的機會。 將雙胍類藥物與胰島素增敏藥物等補充藥物合併使用可以改善血糖控制並最大限度地減少副作用。 該策略不僅解決了糖尿病的多方面性質，而且還為患者提供了多樣化的治療選擇。 投資開創性聯合療法的製藥公司具有策略性定位，可以利用不斷發展的糖尿病管理格局，並透過全面且客製化的解決方案來推進雙胍類藥物市場。

雙胍市場報告要點

2023年，二甲雙胍憑藉其功效、安全性和實惠的價格佔據了很大的市場份額。

到 2023 年，由於患者取得方便且可獲得性廣泛，零售藥局業務佔據了很大的收入份額。

2023年，由於糖尿病患者增加和人口老化，北美地區將主導全球市場。

市場包括阿斯特捷利康、拜耳股份公司、勃林格殷格翰、雷迪博士實驗室、禮來公司、葛蘭素史克和輝瑞公司。

目錄

第1章簡介

第 2 章執行摘要

第3章研究方法

第4章全球雙胍市場洞察

  • 雙胍市場-產業概況
  • 雙胍市場動態
    • 推動者和機會
      • 第一線治療預計將刺激對該產品的需求
      • 2 型糖尿病的激增預計將推動市場成長
    • 抑制因素和挑戰
      • 副作用的普遍存在可能會阻礙市場成長
  • 杵分析
  • 雙胍行業趨勢
  • 價值鏈分析
  • COVID-19 感染的影響分析

第5章全球雙胍市場，依類型

  • 主要發現
  • 簡介
  • 二甲雙胍
  • 苯乙雙胍
  • 其他

第 6 章全球雙胍市場（依分銷通路）

  • 主要發現
  • 簡介
  • 零售藥局
  • 醫院藥房
  • 其他

第 7 章全球雙胍市場（按地區）

  • 主要發現
  • 簡介
    • 雙胍市場評估，地區，2019-2032
  • 雙胍市場 - 北美
    • 北美：雙胍類市場，依通路劃分，2019-2032 年
    • 北美：雙胍類市場，依類型，2019-2032 年
    • 雙胍市場-美國
    • 雙胍市場 - 加拿大
  • 雙胍市場 - 歐洲
    • 歐洲：雙胍類市場，依通路劃分，2019-2032 年
    • 歐洲：雙胍類市場，依類型，2019-2032 年
    • 雙胍市場 - 英國
    • 雙胍市場 - 法國
    • 雙胍市場 - 德國
    • 雙胍市場-義大利
    • 雙胍市場 - 西班牙
    • 雙胍市場 - 荷蘭
    • 雙胍市場 - 俄羅斯
  • 雙胍市場 - 亞太地區
    • 亞太地區：雙胍類市場，依通路劃分，2019-2032 年
    • 亞太地區：雙胍類市場，依類型，2019-2032 年
    • 雙胍市場 - 中國
    • 雙胍市場-印度
    • 雙胍市場 - 馬來西亞
    • 雙胍市場-日本
    • 雙胍市場-印度尼西亞
    • 雙胍市場-韓國
  • 雙胍類市場 - 中東和非洲
    • 中東與非洲：雙胍類市場，依通路劃分，2019-2032 年
    • 中東和非洲：雙胍類市場，按類型，2019-2032 年
    • 雙胍市場-沙烏地阿拉伯
    • 雙胍市場 - 阿拉伯聯合大公國
    • 雙胍市場——以色列
    • 雙胍市場-南非
  • 雙胍市場 - 拉丁美洲
    • 拉丁美洲：雙胍類市場，依通路劃分，2019-2032 年
    • 拉丁美洲：雙胍類市場，按類型，2019-2032 年
    • 雙胍市場 - 墨西哥
    • 雙胍市場－巴西
    • 雙胍市場-阿根廷

第8章競爭態勢

  • 擴張與收購分析
    • 放大
    • 收購
  • 夥伴關係/協作/協議/揭露

第9章公司簡介

  • AstraZeneca
  • Bayer AG
  • Boehringer Ingelheim
  • Bristol Myers Squibb
  • Dr. Reddy's Laboratories
  • Eli Lilly and Company
  • GlaxoSmithKline
  • Lupin Pharmaceuticals, Inc.
  • Merck & Co., Inc.
  • Novartis
  • Pfizer Inc.
  • Sanofi
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Zydus Cadila
Product Code: PM4410

The global Biguanides market size is expected to reach USD 6.19 billion by 2032, according to a new study by Polaris Market Research. The report "Biguanides Market Share, Size, Trends, Industry Analysis Report, By Type (Metformin, Phenformin, Others); By Distribution Channel; By Region; Segment Forecast, 2024- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Ongoing efforts focus on innovating formulations, exploring combination therapies, and expanding the applications of biguanides in diabetes care. The commitment to enhancing clinical efficacy, safety, and patient outcomes is evident in the exploration of novel drug delivery systems and formulations. Research also investigates potential cardiometabolic benefits beyond glycemic control, broadening the therapeutic scope of biguanides. Collaborations between pharmaceutical entities and academic institutions drive innovation, ensuring that ongoing research contributes to the sustained significance of biguanides in the dynamic landscape of antidiabetic therapies.

Telehealth integration is a driving force behind the growth of the biguanides market. As diabetes management evolves towards personalized care, telehealth platforms streamline remote patient monitoring for better outcomes. Real-time tracking of blood glucose levels and medication adherence enhances the efficacy of biguanides, particularly in diabetes treatment. Virtual consultations enable prompt adjustments to medication regimens, fostering patient engagement. This integration not only improves patient care but also contributes valuable data for ongoing research in diabetes management. The convenience offered by telehealth enhances patient compliance, fueling the demand for biguanides and propelling market expansion.

Patient-centric formulations are driving the expansion of the biguanides market. Aligned with the trend towards personalized healthcare, these tailored formulations, including extended-release options, boost the appeal and efficacy of biguanides. They enhance medication adherence by minimizing side effects and simplifying dosing regimens, prioritizing patient comfort and compliance. Improved satisfaction and adherence not only optimize treatment outcomes but also heighten the market desirability of biguanides.

Combination therapies are propelling biguanides market growth by exploring synergies between biguanides and other therapeutic classes. This research and development avenue offers novel opportunities for heightened treatment efficacy. By combining biguanides with complementary drugs like insulin sensitizers, there's potential for improved glycemic control and minimized side effects. This strategy not only tackles the multifaceted nature of diabetes but also diversifies treatment options for patients. Pharmaceutical companies investing in pioneering combination therapies strategically position themselves to leverage the evolving diabetes management landscape, advancing the biguanides market with comprehensive and tailored solutions.

Biguanides Market Report Highlights

In 2023, the metformin segment accounted for significant market share owing to efficacy, safety profile, and affordability.

In 2023, the retail pharmacy segment held significant revenue share owing to convenient access for patients and widespread availability.

In 2023, North America region dominated the global market due to rising diabetes cases, and an aging population.

The market is highly competitive owing to the existence of market players with a global presence, including AstraZeneca, Bayer AG, Boehringer Ingelheim, Dr. Reddy's Laboratories, Eli Lilly and Company, GlaxoSmithKline, Pfizer Inc., and Sanofi among others.

Polaris Market Research has segmented the Biguanides market report based on type, distribution channel, and region:

Biguanides, Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Metformin
  • Phenformin
  • Others

Biguanides, Distribution Channel Outlook (Revenue - USD Billion, 2019 - 2032)

  • Retail Pharmacy
  • Hospital Pharmacy
  • Others

Biguanides, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • France
  • Germany
  • UK
  • Italy
  • Netherlands
  • Spain
  • Russia
  • Asia Pacific
  • Japan
  • China
  • India
  • Malaysia
  • Indonesia
  • South Korea
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Biguanides Market Insights

  • 4.1. Biguanides Market - Industry Snapshot
  • 4.2. Biguanides Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. First-Line Treatment is projected to spur the product demand
      • 4.2.1.2. Surging prevalence of type 2 diabetes is expected to drive market growth
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Prevalence of side effects is likely to impede the market growth
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Biguanides Industry trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Biguanides Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Biguanides, by Type, 2019-2032 (USD Billion)
  • 5.3. Metformin
    • 5.3.1. Global Biguanides Market, by Metformin, by Region, 2019-2032 (USD Billion)
  • 5.4. Phenformin
    • 5.4.1. Global Biguanides Market, by Phenformin, by Region, 2019-2032 (USD Billion)
  • 5.5. Others
    • 5.5.1. Global Biguanides Market, by Others, by Region, 2019-2032 (USD Billion)

6. Global Biguanides Market, by Distribution Channel

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 6.3. Retail Pharmacy
    • 6.3.1. Global Biguanides Market, by Retail Pharmacy, by Region, 2019-2032 (USD Billion)
  • 6.4. Hospital Pharmacy
    • 6.4.1. Global Biguanides Market, by Hospital Pharmacy, by Region, 2019-2032 (USD Billion)
  • 6.5. Others
    • 6.5.1. Global Biguanides Market, by Others, by Region, 2019-2032 (USD Billion)

7. Global Biguanides Market, by Geography

  • 7.1. Key findings
  • 7.2. Introduction
    • 7.2.1. Biguanides Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 7.3. Biguanides Market - North America
    • 7.3.1. North America: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 7.3.2. North America: Biguanides Market, by Type, 2019-2032 (USD Billion)
    • 7.3.3. Biguanides Market - U.S.
      • 7.3.3.1. U.S.: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 7.3.3.2. U.S.: Biguanides Market, by Type, 2019-2032 (USD Billion)
    • 7.3.4. Biguanides Market - Canada
      • 7.3.4.1. Canada: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 7.3.4.2. Canada: Biguanides Market, by Type, 2019-2032 (USD Billion)
  • 7.4. Biguanides Market - Europe
    • 7.4.1. Europe: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 7.4.2. Europe: Biguanides Market, by Type, 2019-2032 (USD Billion)
    • 7.4.3. Biguanides Market - UK
      • 7.4.3.1. UK: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 7.4.3.2. UK: Biguanides Market, by Type, 2019-2032 (USD Billion)
    • 7.4.4. Biguanides Market - France
      • 7.4.4.1. France: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 7.4.4.2. France: Biguanides Market, by Type, 2019-2032 (USD Billion)
    • 7.4.5. Biguanides Market - Germany
      • 7.4.5.1. Germany: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 7.4.5.2. Germany: Biguanides Market, by Type, 2019-2032 (USD Billion)
    • 7.4.6. Biguanides Market - Italy
      • 7.4.6.1. Italy: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 7.4.6.2. Italy: Biguanides Market, by Type, 2019-2032 (USD Billion)
    • 7.4.7. Biguanides Market - Spain
      • 7.4.7.1. Spain: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 7.4.7.2. Spain: Biguanides Market, by Type, 2019-2032 (USD Billion)
    • 7.4.8. Biguanides Market - Netherlands
      • 7.4.8.1. Netherlands: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 7.4.8.2. Netherlands: Biguanides Market, by Type, 2019-2032 (USD Billion)
    • 7.4.9. Biguanides Market - Russia
      • 7.4.9.1. Russia: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 7.4.9.2. Russia: Biguanides Market, by Type, 2019-2032 (USD Billion)
  • 7.5. Biguanides Market - Asia Pacific
    • 7.5.1. Asia Pacific: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 7.5.2. Asia Pacific: Biguanides Market, by Type, 2019-2032 (USD Billion)
    • 7.5.3. Biguanides Market - China
      • 7.5.3.1. China: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 7.5.3.2. China: Biguanides Market, by Type, 2019-2032 (USD Billion)
    • 7.5.4. Biguanides Market - India
      • 7.5.4.1. India: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 7.5.4.2. India: Biguanides Market, by Type, 2019-2032 (USD Billion)
    • 7.5.5. Biguanides Market - Malaysia
      • 7.5.5.1. Malaysia: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 7.5.5.2. Malaysia: Biguanides Market, by Type, 2019-2032 (USD Billion)
    • 7.5.6. Biguanides Market - Japan
      • 7.5.6.1. Japan: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 7.5.6.2. Japan: Biguanides Market, by Type, 2019-2032 (USD Billion)
    • 7.5.7. Biguanides Market - Indonesia
      • 7.5.7.1. Indonesia: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 7.5.7.2. Indonesia: Biguanides Market, by Type, 2019-2032 (USD Billion)
    • 7.5.8. Biguanides Market - South Korea
      • 7.5.8.1. South Korea: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 7.5.8.2. South Korea: Biguanides Market, by Type, 2019-2032 (USD Billion)
  • 7.6. Biguanides Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 7.6.2. Middle East & Africa: Biguanides Market, by Type, 2019-2032 (USD Billion)
    • 7.6.3. Biguanides Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 7.6.3.2. Saudi Arabia: Biguanides Market, by Type, 2019-2032 (USD Billion)
    • 7.6.4. Biguanides Market - UAE
      • 7.6.4.1. UAE: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 7.6.4.2. UAE: Biguanides Market, by Type, 2019-2032 (USD Billion)
    • 7.6.5. Biguanides Market - Israel
      • 7.6.5.1. Israel: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 7.6.5.2. Israel: Biguanides Market, by Type, 2019-2032 (USD Billion)
    • 7.6.6. Biguanides Market - South Africa
      • 7.6.6.1. South Africa: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 7.6.6.2. South Africa: Biguanides Market, by Type, 2019-2032 (USD Billion)
  • 7.7. Biguanides Market - Latin America
    • 7.7.1. Latin America: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 7.7.2. Latin America: Biguanides Market, by Type, 2019-2032 (USD Billion)
    • 7.7.3. Biguanides Market - Mexico
      • 7.7.3.1. Mexico: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 7.7.3.2. Mexico: Biguanides Market, by Type, 2019-2032 (USD Billion)
    • 7.7.4. Biguanides Market - Brazil
      • 7.7.4.1. Brazil: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 7.7.4.2. Brazil: Biguanides Market, by Type, 2019-2032 (USD Billion)
    • 7.7.5. Biguanides Market - Argentina
      • 7.7.5.1. Argentina: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 7.7.5.2. Argentina: Biguanides Market, by Type, 2019-2032 (USD Billion)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. AstraZeneca
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. Bayer AG
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development
  • 9.3. Boehringer Ingelheim
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product Benchmarking
    • 9.3.4. Recent Development
  • 9.4. Bristol Myers Squibb
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product Benchmarking
    • 9.4.4. Recent Development
  • 9.5. Dr. Reddy's Laboratories
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Development
  • 9.6. Eli Lilly and Company
    • 9.6.1. Company Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product Benchmarking
    • 9.6.4. Recent Development
  • 9.7. GlaxoSmithKline
    • 9.7.1. Company Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product Benchmarking
    • 9.7.4. Recent Development
  • 9.8. Lupin Pharmaceuticals, Inc.
    • 9.8.1. Company Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product Benchmarking
    • 9.8.4. Recent Development
  • 9.9. Merck & Co., Inc.
    • 9.9.1. Company Overview
    • 9.9.2. Financial Performance
    • 9.9.3. Product Benchmarking
    • 9.9.4. Recent Development
  • 9.10. Novartis
    • 9.10.1. Company Overview
    • 9.10.2. Financial Performance
    • 9.10.3. Product Benchmarking
    • 9.10.4. Recent Development
  • 9.11. Pfizer Inc.
    • 9.11.1. Company Overview
    • 9.11.2. Financial Performance
    • 9.11.3. Product Benchmarking
    • 9.11.4. Recent Development
  • 9.12. Sanofi
    • 9.12.1. Company Overview
    • 9.12.2. Financial Performance
    • 9.12.3. Product Benchmarking
    • 9.12.4. Recent Development
  • 9.13. Sun Pharmaceutical Industries Ltd.
    • 9.13.1. Company Overview
    • 9.13.2. Financial Performance
    • 9.13.3. Product Benchmarking
    • 9.13.4. Recent Development
  • 9.14. Teva Pharmaceutical Industries Ltd.
    • 9.14.1. Company Overview
    • 9.14.2. Financial Performance
    • 9.14.3. Product Benchmarking
    • 9.14.4. Recent Development
  • 9.15. Zydus Cadila
    • 9.15.1. Company Overview
    • 9.15.2. Financial Performance
    • 9.15.3. Product Benchmarking
    • 9.15.4. Recent Development

List of Tables

  • Table 1 Global Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 2 Global Biguanides Market, by Type, 2019-2032 (USD Billion)
  • Table 3 Biguanides Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 4 North America: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 5 North America: Biguanides Market, by Type, 2019-2032 (USD Billion)
  • Table 6 U.S.: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 7 U.S.: Biguanides Market, by Type, 2019-2032 (USD Billion)
  • Table 8 Canada: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 9 Canada: Biguanides Market, by Type, 2019-2032 (USD Billion)
  • Table 10 Europe: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 11 Europe: Biguanides Market, by Type, 2019-2032 (USD Billion)
  • Table 12 UK: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 13 UK: Biguanides Market, by Type, 2019-2032 (USD Billion)
  • Table 14 France: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 15 France: Biguanides Market, by Type, 2019-2032 (USD Billion)
  • Table 16 Germany: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 17 Germany: Biguanides Market, by Type, 2019-2032 (USD Billion)
  • Table 18 Italy: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 19 Italy: Biguanides Market, by Type, 2019-2032 (USD Billion)
  • Table 20 Spain: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 21 Spain: Biguanides Market, by Type, 2019-2032 (USD Billion)
  • Table 22 Netherlands: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 23 Netherlands: Biguanides Market, by Type, 2019-2032 (USD Billion)
  • Table 24 Russia: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 25 Russia: Biguanides Market, by Type, 2019-2032 (USD Billion)
  • Table 26 Asia Pacific: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 27 Asia Pacific: Biguanides Market, by Type, 2019-2032 (USD Billion)
  • Table 28 China: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 29 China: Biguanides Market, by Type, 2019-2032 (USD Billion)
  • Table 30 India: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 31 India: Biguanides Market, by Type, 2019-2032 (USD Billion)
  • Table 32 Malaysia: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 33 Malaysia: Biguanides Market, by Type, 2019-2032 (USD Billion)
  • Table 34 Japan: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 35 Japan: Biguanides Market, by Type, 2019-2032 (USD Billion)
  • Table 36 Indonesia: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 37 Indonesia: Biguanides Market, by Type, 2019-2032 (USD Billion)
  • Table 38 South Korea: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 39 South Korea: Biguanides Market, by Type, 2019-2032 (USD Billion)
  • Table 40 Middle East & Africa: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 41 Middle East & Africa: Biguanides Market, by Type, 2019-2032 (USD Billion)
  • Table 42 Saudi Arabia: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 43 Saudi Arabia: Biguanides Market, by Type, 2019-2032 (USD Billion)
  • Table 44 UAE: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 45 UAE: Biguanides Market, by Type, 2019-2032 (USD Billion)
  • Table 46 Israel: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 47 Israel: Biguanides Market, by Type, 2019-2032 (USD Billion)
  • Table 48 South Africa: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 49 South Africa: Biguanides Market, by Type, 2019-2032 (USD Billion)
  • Table 50 Latin America: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 51 Latin America: Biguanides Market, by Type, 2019-2032 (USD Billion)
  • Table 52 Mexico: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 53 Mexico: Biguanides Market, by Type, 2019-2032 (USD Billion)
  • Table 54 Brazil: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 55 Brazil: Biguanides Market, by Type, 2019-2032 (USD Billion)
  • Table 56 Argentina: Biguanides Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 57 Argentina: Biguanides Market, by Type, 2019-2032 (USD Billion)

List of Figures

  • Figure 1 Global Biguanides Market, 2019-2032 (USD Billion)
  • Figure 2 Integrated Ecosystem
  • Figure 3 Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4 Market by Geography
  • Figure 5 Porter's Five Forces
  • Figure 6 Market by Distribution Channel
  • Figure 7 Global Biguanides Market, by Distribution Channel, 2022 & 2032 (USD Billion)
  • Figure 8 Market by Type
  • Figure 9 Global Biguanides Market, by Type, 2022 & 2032 (USD Billion)
  • Figure 10 Biguanides Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 11 Strategic Analysis - Biguanides Market